Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn’s Disease Treated With Infliximab [Remicade®] or Conventional Therapy.

Autor:	D’Haens, Geert1 (AUTHOR) g.dhaens@amc.uva.nl, Reinisch, Walter2 (AUTHOR), Colombel, Jean-Frederic3 (AUTHOR), Panes, Julian4 (AUTHOR), Ghosh, Subrata5 (AUTHOR), Prantera, Cosimo6 (AUTHOR), Lindgren, Stefan7 (AUTHOR), Hommes, Daniel W.8 (AUTHOR), Zhiping Huang9 (AUTHOR), Boice, Judith9 (AUTHOR), Huyck, Susan9 (AUTHOR), Cornillie, Freddy10 (AUTHOR)
Zdroj:	Journal of Crohn's & Colitis. Jun2017, Vol. 11 Issue 6, p680-689. 10p. 7 Charts.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu